Home Gilead Sciences

Gilead Sciences

In operation
Post-IPO Round
Antiviral Drug Developer
Basic
Enterprise Profile

Basic Information

Gilead Sciences, Inc. was founded in 1987, with its headquarters located in California. It is a biopharmaceutical company engaged in the development and sale of pharmaceuticals based on research. The company focuses on areas such as human immunodeficiency virus (HIV)/AIDS, liver diseases, and more.
Gilead Sciences, Inc.
California,United States of America
more than 500 people
June 22, 1987
public_affairs@gilead.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations Immune Cell Therapy Biological Drug Production
Technology
Gene Technology Targeted Technology Immunological Techniques Cell Technology Protein Technology Antibacterial/Antiviral Technology
Concept
Infectious Diseases Department Infectious Diseases Therapeutic Products Lung Cancer Esophageal Cancer Lymphoma Leukemia
Application Scenarios
Chemical Drug Innovative Drugs Bispecific Antibody ADC (Antibody-Drug Conjugate) Cell and Gene Therapy AI+Pharmaceuticals Novel Coronavirus